Open AccessBiennial Analysis of Medication Guide Length and Estimated Readability for New Molecular Entity Drugs, 2011–2017
Author(s) -
Paul R. Jones,
Elisabeth J Walther,
Andrew Nguyen,
Joel Ferreira Santiago,
Bryon M. Pearsall
Publication year - 2021
Publication title -
therapeutic innovation and regulatory science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.569
H-Index - 44
eISSN - 2168-4804
pISSN - 2168-4790
DOI - 10.1007/s43441-021-00270-3
Subject(s) - readability , pharmacy , medicine , index (typography) , reading (process) , medical physics , strengths and weaknesses , psychology , family medicine , computer science , world wide web , linguistics , social psychology , philosophy , programming language
A medication guide (MG) is a form of FDA-approved labeling that provides patients with information about certain prescribed drugs so that patients can use these drugs safely and effectively. Given ongoing efforts by FDA and industry to continuously improve MG content and format, we hypothesized that more recently approved MGs for new molecular entities (NMEs) would be shorter and more readable compared to NME MGs approved earlier.